Patent ID: 11938110
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating SARS-CoV-2 induced COVID-19 in a person who has tested positive for SARS-CoV-2 induced COVID-19, the method comprising administering to the person a pharmaceutically acceptable composition containing a calcium channel blocker component via nasal administration, the calcium channel blocker component comprising an amount of verapamil that is effective to treat the SARS-CoV-2 induced COVID-19, wherein a) the concentration of verapamil in the composition is 15-25 mg/mL, b) the composition is maintained at a pH between 4.09 and 6.09 prior to administration, and c) the composition is administered through a nasal spray device.